June 2021 in “Psychiatria Danubina” The antidepressant escitalopram likely caused hair loss in a patient.
July 2007 in “Journal of Generic Medicines” The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.
6 citations,
December 2008 in “Clinics in Dermatology” Escitalopram might effectively treat delusions of parasitosis and possibly Morgellons disease, with psychological factors being important to consider.
2 citations,
March 2016 in “Düşünen Adam” Switching from escitalopram to duloxetine improved hair loss.
October 2008 in “Journal of Intellectual Property Law & Practice” The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.